Page last updated: 2024-09-03

ym 264 and web 2086

ym 264 has been researched along with web 2086 in 2 studies

Compound Research Comparison

Studies
(ym 264)
Trials
(ym 264)
Recent Studies (post-2010)
(ym 264)
Studies
(web 2086)
Trials
(web 2086)
Recent Studies (post-2010) (web 2086)
900600831

Protein Interaction Comparison

ProteinTaxonomyym 264 (IC50)web 2086 (IC50)
Platelet-activating factor receptorCavia porcellus (domestic guinea pig)0.1093
Platelet-activating factor receptorHomo sapiens (human)0.1735

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T1
Bird, IN; Daniels, RH; Elmore, MA; Finnen, MJ; Hill, ME1

Other Studies

2 other study(ies) available for ym 264 and web 2086

ArticleYear
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
    Biochemical and biophysical research communications, 1991, Apr-30, Volume: 176, Issue:2

    Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles

1991
Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
    Journal of immunology (Baltimore, Md. : 1950), 1994, Oct-15, Volume: 153, Issue:8

    Topics: Arachidonic Acid; Azepines; Cell Adhesion; Cell Movement; Cell Polarity; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-1; Neutrophil Activation; Neutrophils; Piperazines; Platelet Activating Factor; Superoxides; Thiazoles; Thiazolidines; Triazoles

1994